PROVIDER PROFILE · NPI 1811982291

Christopher Lin

OphthalmologyEureka, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

567

Beneficiaries

—

Total drug cost

$110K

Distinct drugs

Brand share

43.9%

Top prescribed drugs

Latanoprost186 claims

Bimatoprost111 claims

Timolol Maleate64 claims

Dorzolamide Hcl/Timolol Maleat52 claims

Brimonidine Tartrate31 claims

QUALITY · MIPS · 2024

Final MIPS score

82.7

Quality

87.3

Cost

59.3

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

0.32%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Christopher Lin's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 65 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Shasta Eye Surgeons Inc Ambulatory Surgical Center · Redding, CA	286	833
DIGNITY HEALTH	135	310
MANDEL, DOUGLAS	74	134
PRIME HEALTHCARE SERVICES - SHASTA LLC	69	98
John Stewart Anesthesiology · Redding, CA	58	137
Richard Maples Family Practice · Redding, CA	52	77
THOMAS, THOMAS	46	100
Ewa Bauer Diagnostic Radiology · Redding, CA	38	55
Everett Trevor Pulmonary Disease · Redding, CA	38	97
Sander Saidman Diagnostic Radiology · Redding, CA	35	49
NPI 1295755445	34	40
Irwin Maier Diagnostic Radiology · Red Bluff, CA	33	38

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history